Cardiotoxicity from Chimeric Antigen Receptor-T Cell Therapy for Advanced Malignancies

Scientists discuss the pertinent cardiovascular risks of the growing field of CAR-T cell therapy for today’s cardiologists, including incidence, characteristics, and treatment options, and will conclude with an integrated management algorithm.